{
    "organizations": [],
    "uuid": "a2d290a3e2f3dd2a4b3596308eafacd9fb2e97ce",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-indias-lupin-gets-fda-approval-for/brief-indias-lupin-gets-fda-approval-for-generic-temovate-ointment-0-05-percent-idUSFWN1SE0CO",
    "ord_in_thread": 0,
    "title": "India's Lupin Gets FDA Approval For Generic Temovate Ointment, 0.05 Percent",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 7 (Reuters) - Lupin Ltd:\n* GETS FDA APPROVAL FOR GENERIC TEMOVATE OINTMENT, 0.05 PERCENT\n* TEMOVATE OINTMENT IS INDICATED FOR RELIEF OF INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTEROID RESPONSIVE DERMATOSES Source text - bit.ly/2rpHWmF\nOur ",
    "published": "2018-05-07T18:28:00.000+03:00",
    "crawled": "2018-05-08T16:39:19.002+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "lupin",
        "ltd",
        "get",
        "fda",
        "approval",
        "generic",
        "temovate",
        "ointment",
        "percent",
        "temovate",
        "ointment",
        "indicated",
        "relief",
        "inflammatory",
        "pruritic",
        "manifestation",
        "corticosteroid",
        "responsive",
        "dermatosis",
        "source",
        "text"
    ]
}